How do proteins efficiently and precisely shift from one conformation to another? show that transient hydrogen bonds are critical to the conformational transition of the nitrogen regulatory protein NtrC between its native state and its active state.
results reveal several novel aspects of translocation mechanisms, but also raise many questions. Why do translocations occur only between TMPRSS2 and its particular translocation partners, when AR binds to many genomic sites? Perhaps other translocations do occur but are lost because they do not provide a growth or survival advantage. Alternatively, the epigenetic makeup of the breakpoint regions, their spatial arrangement, or the involvement of AR cofactors or noncoding RNAs may underlie recurrent translocations. It will be important to characterize the nature of chromatin structure and epigenetic modifications at the breakpoints and to determine how these features influence the recruitment of AR and AID. Also, is AID frequently expressed in prostate carcinoma tissues, and, if so, does it correlate with disease malignancy?
Maybe the most important conceptual implication of the reported findings is the challenge to how we think about translocations. Generally, we have assumed that translocations occur more or less randomly in the genome by stochastic DNA double-strand breaks. The enrichment of particular translocations was then thought to be purely the consequence of a selection process in which only certain subpopulations of cells survive as the randomly generated translocation affords them a growth advantage. This idea needs rethinking. The recent results on blood and solid tumors suggest instead that breaks in the genome occur in a nonrandom fashion and that their sites are determined by where transcription factors bind. It then seems that in addition to selection on the basis of growth properties, recurrent translocations in a tumor may also be a reflection of transcription factor binding patterns and the higher-order chromatin structure landscape. As transcription factor binding and epigenetic patterns are often cell-type specific, they may be a plausible explanation for the cell lineage-and tumor type-specific occurrence of some cancer translocations. An interesting possibility is that we can begin thinking about superimposing currently available transcription factor binding and epigenetic maps with the locations of breakpoints in a wide array of cancers and in this way identify the molecular triggers of specific cancer translocations. If successful, then we have truly entered a new era in understanding cancer and its translocations.
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Unlike the static protein structures that grace journal pages, real proteins in solution are dynamic. The internal motions of a protein can be depicted schematically in terms of a free-energy landscape-a terrain map describing protein conformational space (Dill and Chan, 1997; Frauenfelder et al., 1991) . Different conformations Methodologies based on nuclear magnetic resonance (NMR) are proving especially powerful for analyzing protein dynamics and energy landscapes. Gardino et al. use a technique known as NMR relaxation dispersion, which provides insight into the kinetics and thermodynamics of conformational exchange and reveals higher-energy conformations that cannot be detected by other techniques (Baldwin and Kay, 2009) . A critical insight from both experiment and theory is that the internal motions of a protein are not entirely random, but rather a protein's intrinsic dynamics bias its fluctuations toward sampling other functionally relevant conformations (Eisenmesser et al., 2005; Boehr et al., 2009) . One striking example is the signaling protein NtrC from the Salmonella typhimurium two-component regulatory system important in nitrogen fixation. Studies from the Kern lab have previously shown that the unphosphorylated form of NtrC thermally fluctuates into a higherenergy conformation that resembles the phosphorylated form. Meaning, there is a pre-existing equilibrium between a major "inactive" and a minor "active" conformation, and phosphorylation merely shifts their relative abundance (Gardino and Kern, 2007; Volkman et al., 2001) . By comparing each conformation to the unfolded state, Gardino et al. now cleverly demonstrate that phosphorylation primarily acts by stabilization of the active conformation rather than destabilization of the inactive form. These studies are remarkable because they not only reveal new insights into the activation mechanism of NtrC, but they also provide a methodology to elucidate the connections between the energy landscapes of folding and function in other proteins.
Folding and function are not truly separate characteristics of a protein, as exemplified by intrinsically disordered proteins that couple binding interactions to folding, but rather, folding and function are part of a single-energy landscape. In well-folded proteins, the functional landscape is only that small portion of the folding landscape that is lowest in free energy. Or to put it another way, the bottom of the folding funnel is not comprised of just one state but rather a number of thermally accessible substates that have some role in protein function. The experimental methodology developed to study NtrC allows for a direct comparison between folding energies and the energy differences between the most functionally relevant conformations, allowing for a more comprehensive view into the energy landscape of folding and function.
Gardino et al. also tackle the question of how the transition between the two conformations occurs. A recently published computational simulation ) suggests that transient hydrogen bonds are responsible for guiding the conversion between inactive and active conformations. As shown by Gardino et al., disruption of these hydrogen bonds through mutation decreases the rate of the conformational change without markedly affecting the stability of either conformation. This is important because it suggests new intricacies to molecular evolution and protein engineering-there must be a careful balance between interactions that stabilize each conformation, interactions that change after a molecular event (for instance, phosphorylation and ligand binding), and transient interactions that are needed to promote the conformational transition (plus any other transient interactions needed for protein folding); these transient contacts should not destabilize the individual functional conformations nor promote off-pathway conformations. Understanding these interactions, their energetic contributions, and the delicate balance among them will likely be needed for future progress in protein engineering. The complexity of this engineering problem may be one limiting factor in nature's exploration of protein conformational space-only certain folds can achieve the proper balance between the various native and transient, nonnative interactions.
Questions remain regarding the nature of the conformational transition energy barriers in NtrC and other proteins. As admitted by the authors, there may be other interactions important for crossing this energetic barrier in NtrC that have not yet been identified. This begs the question of whether there is one dominant or many transition pathways. This is analogous to the challenge in describing protein folding. What pathways contribute, what are their relative contributions, and how do we experimentally characterize and tease them apart? Understanding these transition pathways will likely bring new insights into protein function and regulation and will help to unveil the principles underlying the complex patterns of amino acid evolution within proteins (Suel et al., 2003) . The mammalian embryonic gonad has long been viewed as the ideal model system for the study of organogenesis because it provides a choice between ovary or testis development. The way in which this choice is made can tell us a great deal about the molecular regulation of cell fate and pattern formation during development. In all mammalian embryos, the gonad is "bipotential," that is, it can form either an ovary or a testis. In genetic males (XY), the testis pathway is set in motion by the Sry gene on the Y chromosome (Sinclair et al., 1990) , which activates the related Sox9 gene (Sekido and Lovell-Badge, 2008) . In female (XX) embryos, ovarian development occurs in the absence of Sry, but the molecular mechanisms have remained obscure. One factor that plays a role in embryonic ovarian development is the forkhead/winged-helix transcription factor encoded by the Foxl2 gene. In this issue, Uhlenhaut et al. (2009) now show that, in adult mice, conditional deletion of Foxl2 induces transdifferentiation of the ovary into a functional testis. This finding reveals an important role for Foxl2 in the ovary that extends beyond embryogenesis, and reveals the remarkable plasticity of the adult gonad.
The undifferentiated gonad of mammalian embryos has a population of precursor cell types that can follow either the female or male pathway. These are the so-called supporting cells, the steroidogenic cells and the primordial germ cells (presumptive spermatozoa or oocytes) (Figure 1 ). In the genetic male, activation of Sox9 by Sry leads to the differentiation of the supporting cell lineage into pre-Sertoli cells. These cells organize into seminiferous cords and enclose the germ cells, which are directed to enter mitotic arrest. Signals are also sent to the steroidogenic precursors, which give rise to fetal Leydig cells that synthesize testosterone (Figure 1 ). By contrast, in females, the embryonic supporting cells become granulosa cells of the primordial follicle, the steroidogenic precursors become the theca cells, and the germ cells enter the first stages of meiosis (Figure 1 ). It has recently been shown that β-catenin, activated by the signaling molecules R-spondin1 and Wnt4, is required for ovarian differentiation in the mouse embryo (Liu et al., 2008) . The forkhead transcription factor, Foxl2, also plays a role in ovarian differentiation (Garcia-Ortiz et al., 2009 ). In the mouse embryo, genetic ablation of Foxl2 leads to defects in ovarian development that manifest late in embryogenesis as a failure of granulosa cell development. In humans, heterozygous FOXL2 loss-of-function mutations result in ovarian dysfunction and the autosomal dominant disease blepharophimosis-ptosis-epicanthus inversus.
Which of these factors, Foxl2, Wnt4, or R-Spondin1, is the key embryonic trigger for ovarian determination, akin to Sry in males? Targeted deletion of each of these genes alone results in masculinization of the XX embryonic gonads but does not cause complete testis development. However, testis development can be induced in XX mouse embryos lacking both Wnt4 and 
